Search Results

Effect of dose-rate on nitric oxide-induced apoptosis in A375 human melanoma cells.

• Authors : Seo Hyun Moon¹; Min Young Kim²

• Source: Tropical Journal of Pharmaceutical Research. Apr2024, Vol. 23 Issue 4, p675-681. 7p.

Record details

Current Status and Molecular Mechanisms of Resistance to Immunotherapy in Oral Malignant Melanoma.

• Authors : Usta, Sena Zeynep¹ (AUTHOR) ; Uchihashi, Toshihiro¹ (AUTHOR) ; Kodama, Shingo¹ (AUTHOR)

Subjects: *MELANOMA; *IMMUNE checkpoint inhibitors; *ORAL mucosa

• Source: International Journal of Molecular Sciences. Dec2023, Vol. 24 Issue 24, p17282. 27p.

Record details

Effectiveness of Gold Nanorods of Different Sizes in Photothermal Therapy to Eliminate Melanoma and Glioblastoma Cells.

• Authors : Domingo-Diez, Javier¹ (AUTHOR) ; Souiade, Lilia¹ (AUTHOR) ; Manzaneda-González, Vanesa² (AUTHOR)

Subjects: *NANORODS; *GLIOBLASTOMA multiforme; *CELL death

• Source: International Journal of Molecular Sciences. Sep2023, Vol. 24 Issue 17, p13306. 20p.

Record details

Evolving Acquired Vemurafenib Resistance in a BRAF V600E Mutant Melanoma PDTX Model to Reveal New Potential Targets.

• Authors : Tóvári, József^1,2 (AUTHOR); Vári-Mező, Diána^1,2 (AUTHOR); Surguta, Sára Eszter^1,2 (AUTHOR)

• Source: Cells (2073-4409). Jul2023, Vol. 12 Issue 14, p1919. 19p.

Record details

A Comparative Evaluation of the Photosensitizing Efficiency of Porphyrins, Chlorins and Isobacteriochlorins toward Melanoma Cancer Cells.

• Authors : Castro, Kelly A. D. F.^1,2 (AUTHOR) ; Moura, Nuno M. M.² (AUTHOR) ; Simões, Mário M. Q.² (AUTHOR)

Subjects: *CANCER cells; *CHLORINS; *PORPHYRINS

• Source: Molecules. Jun2023, Vol. 28 Issue 12, p4716. 15p.

Record details

Harnessing the Potential of Non-Apoptotic Cell Death Processes in the Treatment of Drug-Resistant Melanoma.

• Authors : Dong, Linyinxue^1,2,3 (AUTHOR) ; Vargas, Ceeane Paul Dagoc³ (AUTHOR) ; Tian, Xuechen^1,2,3 (AUTHOR)

Subjects: *CELL death; *MELANOMA; *SKIN cancer

• Source: International Journal of Molecular Sciences. Jun2023, Vol. 24 Issue 12, p10376. 20p.

Record details

The therapeutic potential of targeting minimal residual disease in melanoma.

• Authors : Patel, Riyaben P^1,2 (AUTHOR); Somasundram, Pretashini M³ (AUTHOR); Smith, Lorey K.^1,2 (AUTHOR)

• Source: Clinical & Translational Medicine. Mar2023, Vol. 13 Issue 3, p1-15. 15p.

Record details

Histone Deacetylase (HDAC) Inhibitors: A Promising Weapon to Tackle Therapy Resistance in Melanoma.

• Authors : Palamaris, Kostas¹ (AUTHOR) ; Moutafi, Myrto^1,2 (AUTHOR) ; Gakiopoulou, Hariklia¹ (AUTHOR)

Subjects: *HISTONE deacetylase; *HEMATOLOGIC malignancies; *MELANOMA

• Source: International Journal of Molecular Sciences. Apr2022, Vol. 23 Issue 7, p3660-N.PAG. 20p.

Record details

Prognostic biomarkers for predicting papillary thyroid carcinoma patients at high risk using nine genes of apoptotic pathway.

• Authors : Arora, Chakit¹ (AUTHOR); Kaur, Dilraj¹ (AUTHOR); Naorem, Leimarembi Devi¹ (AUTHOR)

Subjects: *PROGNOSIS; *PAPILLARY carcinoma; *THYROID cancer

• Source: PLoS ONE. 11/12/2021, Vol. 16 Issue 11, p1-19. 19p.

Record details

Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction.

• Authors : Ito, Reina E.^1,2 (AUTHOR); Oneyama, Chitose³ (AUTHOR); Aoki, Kazuhiro^1,2,4 (AUTHOR)

Subjects: *BRAF genes; *ADDICTIONS; *ONCOGENES

• Source: PLoS ONE. 4/1/2021, Vol. 16 Issue 4, p1-19. 19p.

Record details